SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic

BACKGROUND: During the COVID-19 outbreak, healthcare professionals (HCP) are at the frontline of clinical management and at increased risk for infection. The SARS-CoV-2 seroprevalence of oncological HCP and their patients has significant implications for oncological care. METHODS: HCP and patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuereder, Thorsten, Berghoff, Anna Sophie, Heller, Gerwin, Haslacher, Helmuth, Perkmann, Thomas, Strassl, Robert, Berger, Julia Maria, Puhr, Hannah Christina, Kreminger, Judith, Moik, Florian, Schubert, Lorenz, Starzer, Angelika Martina, Steindl, Ariane, Winkler, Stefan, Preusser, Matthias, Tobudic, Selma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470513/
https://www.ncbi.nlm.nih.gov/pubmed/32878898
http://dx.doi.org/10.1136/esmoopen-2020-000889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470513/
https://www.ncbi.nlm.nih.gov/pubmed/32878898
http://dx.doi.org/10.1136/esmoopen-2020-000889

Ejemplares similares